Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
MDCX
MDCX
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
MDCX News
Medicus Pharma Receives FDA Clearance for Teverelix Study
6d ago
Newsfilter
Medicus Pharma to Ring Nasdaq Opening Bell on January 22, 2026, Celebrating One-Year Anniversary
Jan 20 2026
Globenewswire
Medicus Pharma Rings Nasdaq Opening Bell to Celebrate One-Year Listing Anniversary
Jan 20 2026
Newsfilter
Medicus Pharma (NASDAQ: MDCX) Announces Teverelix Clinical Data Accepted for AACE 2026 Presentation
Jan 12 2026
Globenewswire
Medicus Pharma Names Carolyn Bonner as CFO and President
Dec 01 2025
NASDAQ.COM
Medicus Pharma names new Chief Financial Officer
Dec 01 2025
SeekingAlpha
D. Boral Capital Reiterates Buy Rating for Medicus Pharma with $27 Price Target
Oct 29 2025
Benzinga
Medicus Pharma Ltd. announces second quarter results
Aug 21 2025
SeekingAlpha
D. Boral Capital Maintains Buy on Medicus Pharma, Maintains $27 Price Target
Aug 13 2025
Benzinga
D. Boral Capital Maintains Buy on Medicus Pharma, Maintains $27 Price Target
Aug 05 2025
Benzinga
Following the Filing for the Opening of Reorganization Proceedings, Poxel Announces Changes to Its Corporate Governance
Aug 01 2025
Newsfilter
D. Boral Capital Maintains Buy on Medicus Pharma, Maintains $27 Price Target
Jul 09 2025
Benzinga
Medicus Pharma to acquire Antev
Jun 30 2025
SeekingAlpha
Nasdaq Down 100 Points; Chicago PMI Dips In May
May 30 2025
Benzinga
Why UiPath Shares Are Trading Higher By Over 13%; Here Are 20 Stocks Moving Premarket
May 30 2025
Benzinga
Quantum BioPharma Receives $2.35 Million USD from a Mutually-Agreed Global Legal Settlement with Dr. Raza Bokhari
May 30 2025
Newsfilter
Show More News
